Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BVMF/I1QV34 stock hub

BVMF/I1QV34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/I1QV34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
146.1B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/I1QV34
In the news

Latest news · BVMF/I1QV34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5
P25 11.3P50 14.6P75 19.6
Trailing P/E20.2
P25 15.2P50 21.5P75 27.3
ROE22.5
P25 5.3P50 12.3P75 22.5
ROIC9.6
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/I1QV34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
USD
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
93,000
Employees Change
5,000%
Employees Change Percent
5.68
Enterprise value
BRL 215.8B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Diagnostics & Research
Last refreshed
2026-05-10
Market cap
BRL 146.1B
Price
BRL 219
Price currency
BRL
Rev Per Employee
932,952.37x
Sector
Healthcare
Sic
8731
Symbol
bvmf/I1QV34
Website
https://www.iqvia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.95%
EV Earnings
29.87x
EV/EBIT
18.52x
EV/EBITDA
13.76x
EV/FCF
19.55x
EV/Sales
2.65x
FCF yield
7.56%
Forward P/E
13.47x
P/B ratio
4.41x
P/E ratio
20.22x
P/S ratio
1.68x
PE Ratio10 Y
76.5x
PE Ratio3 Y
28.21x
PE Ratio5 Y
35.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
14.06%
EBITDA Margin
18.04%
FCF margin
12.72%
Gross margin
32.99%
Gross Profit
BRL 28.6B
Gross Profit Growth
1.99%
Gross Profit Growth Q
4.39%
Gross Profit Growth3 Y
2.89%
Gross Profit Growth5 Y
6.29%
Net Income
BRL 7.2B
Net Income Growth
3.82%
Net Income Growth Q
10.04%
Net Income Growth3 Y
9.5%
Net Income Growth5 Y
27.63%
Pretax Margin
9.84%
Profit Margin
8.33%
Profit Per Employee
BRL 77,690
ROA
5.13
Roa5y
4.73
ROCE
10.95
ROE
22.49
Roe5y
20.22
ROIC
9.6
Roic5y
9.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
2.18%
Cagr3y
-1.77%
Cagr5y
-6.74%
EPS Growth
9.9
EPS Growth Q
15
EPS Growth3 Y
13.21
EPS Growth5 Y
30.9
FCF Growth
-2.17%
FCF Growth Q
15.26%
FCF Growth3 Y
11.95%
FCF Growth5 Y
0.74%
OCF Growth
-2.1%
OCF Growth Q
8.8%
OCF Growth10 Y
15.28%
OCF Growth3 Y
7.63%
OCF Growth5 Y
0.31%
Revenue Growth
7.32x
Revenue Growth Q
8.41x
Revenue Growth3 Y
4.69x
Revenue Growth5 Y
6.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.58
Assets
BRL 154.8B
Cash
BRL 11B
Current Assets
BRL 30.6B
Current Liabilities
BRL 40.9B
Debt
BRL 84.6B
Debt EBITDA
BRL 5.13
Debt Equity
BRL 2.55
Debt FCF
BRL 7.66
Equity
BRL 33.1B
Interest Coverage
3.09
Liabilities
BRL 121.7B
Long Term Assets
BRL 124.2B
Long Term Liabilities
BRL 80.8B
Net Cash
BRL -73.6B
Net Cash By Market Cap
BRL -50.4
Net Debt EBITDA
BRL 4.7
Net Debt Equity
BRL 2.22
Net Debt FCF
BRL 6.67
Tangible Book Value
BRL -78.9B
Tangible Book Value Per Share
BRL -473
WACC
8.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.75
Net Working Capital
BRL -11.6B
Quick ratio
0.66
Working Capital
BRL -11B
Working Capital Turnover
BRL -51.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
5.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
2.18%
200-day SMA
264.5
3Y total return
-5.21%
50-day SMA
253.4
50-day SMA vs 200-day SMA
50under200
5Y total return
-29.44%
All Time High
399
All Time High Change
-45.03%
All Time High Date
2021-12-27
All Time Low
109.5
All Time Low Change
100.38%
All Time Low Date
2020-03-18
ATR
6.74
Beta
1.18
Ch YTD
-28.46
High
219.3
High52
322.3
High52 Date
2026-01-21
High52ch
-31.95%
Low
216.3
Low52
197.2
Low52 Date
2026-05-04
Low52ch
11.21%
Ma50ch
-13.46%
Price vs 200-day SMA
-17.08%
RSI
45.3
RSI Monthly
43.48
RSI Weekly
43.3
Sharpe ratio
-0.18x
Sortino ratio
-0.17
Total Return
5.55%
Tr YTD
-28.46
Tr1m
-0.01%
Tr1w
11.21%
Tr3m
-17.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 12.2B
Operating Income Growth
2.41
Operating Income Growth Q
7.62
Operating Income Growth3 Y
8.19
Operating Income Growth5 Y
19.64
Operating margin
14.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
158,532,032%
Net Borrowing
6,142,750,000
Shares Insiders
0.97%
Shares Institutions
100.06%
Shares Qo Q
-1.22%
Shares Yo Y
-5.55%
Short Ratio
2.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
BRL 9.8B
Average Volume
130.65x
Bv Per Share
194.4
CAPEX
BRL -3.1B
Ch1m
-0.01
Ch1w
11.21
Ch1y
2.18
Ch3m
-17.56
Ch3y
-5.21
Ch5y
-29.44
Ch6m
-26.14
Change
1.41%
Change From Open
1.41
Close
216.3
Days Gap
0
Depreciation Amortization
3,258,114,600
Dollar Volume
5,921.6
Earnings Date
2026-05-05
EBIT
BRL 12.2B
EBITDA
BRL 15.7B
EPS
BRL 42.11
F Score
5
FCF
BRL 11B
FCF EV Yield
5.11x
Financing CF
-1,695,435,625
Fiscal Year End
December
Goodwill
81,300,524,800
Graham Number
110.16826
Graham Upside
-49.77
Income Tax
BRL 1.3B
Investing CF
-11,455,928,100
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Lynch Fair Value
BRL 271
Lynch Upside
23.65
Ma150
261.7
Ma150ch
-16.18%
Ma20
217.3
Ma20ch
0.93%
Net CF
1,079,862,075
Open
216.3
P FCF Ratio
13.23
P OCF Ratio
10.36
Position In Range
100
Ppne
3,975,587,800
Price Date
2026-05-08
Price EBITDA
BRL 9.33
Relative Volume
0.21x
Revenue
86,764,570,200x
SBC By Revenue
1.44x
Share Based Comp
1,252,014,000
Tax By Revenue
1.5x
Tax Rate
15.27%
Tr6m
-26.14%
Volume
27
Z Score
1.92
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/I1QV34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/I1QV34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.2%
S&P 500 1Y: n/a
3Y total return
-5.2%
S&P 500 3Y: n/a
5Y total return
-29.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/I1QV34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+100.1%
Share of float held by funds and institutions
Insider ownership
+1.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.4 days to cover
Y/Y dilution
-5.5%
Negative means the company is buying back shares.
Technical

BVMF/I1QV34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.3
Neutral momentum band
Price vs 200-day MA
-17.1%
50/200-day relationship not available
Beta (5Y)
1.18
Moves roughly with the market
Sharpe ratio
-0.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/I1QV34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/I1QV34 stock rating?

bvmf/I1QV34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/I1QV34 analysis?

The full report lives at /stocks/bvmf/I1QV34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/I1QV34?

The latest report frames bvmf/I1QV34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/I1QV34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bvmf/I1QV34 stock profile: metrics, valuation and analysis | AI-Agent voor de Aandelenmarkt